XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement of Changes in Equity - USD ($)
$ in Millions
Total
Cumulative effect, period of adoption, adjustment
Total
Total
Cumulative effect, period of adoption, adjustment
Common Shares
Common Stock and Capital Surplus
Retained Earnings
Retained Earnings
Cumulative effect, period of adoption, adjustment
Accumulated Other Comprehensive Inc. (Loss)
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect of accounting change $ 6,269 $ 7 $ 6,269 $ 7   $ 1,397 $ 4,009 $ 7 $ 863 $ 0
Beginning Balance, shares at Dec. 31, 2019         90,303,686          
Beginning Balance at Dec. 31, 2019 6,269 $ 7 6,269 $ 7   1,397 4,009 $ 7 863 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) attributable to parent 732   732       732      
Net income (loss), including portion attributable to nonredeemable noncontrolling interest 734                 2
Other comprehensive income (loss) 416   414           414 0
Other comprehensive income (loss), including portion attributable to noncontrolling interest 414                  
Dividends (336)   (336)       (336)      
Shares issued:                    
Exercise of stock options, shares         328,471          
Exercise of stock options 14   14     14        
Restricted stock awards, shares         227,867          
Restricted stock awards 0   0     0        
Other benefit plans, shares         143,270          
Other benefit plans 10   10     10        
Dividend reinvestment plan, shares         18,690          
Dividend reinvestment plan 2   2     2        
Stock-based compensation expense 20   20     20        
Shares acquired and retired, shares         (4,531,394)          
Shares acquired and retired (313)   (313)     (70) (243)      
Shares exchanged — benefit plans, shares         (101,663)          
Shares exchanged — benefit plans (11)   (11)     (2) (9)      
Forfeitures of restricted stock, shares         (43,681)          
Other (21)   (19)     (4) (11)   (4) (2)
Ending Balance, shares at Dec. 31, 2020         86,345,246          
Ending Balance at Dec. 31, 2020 6,789   6,789     1,367 4,149   1,273 0
Beginning Balance, redeemable noncontrolling interests at Dec. 31, 2019 0                  
Redeemable Noncontrolling Interest, Equity, Carrying Amount [Abstract]                    
Net income (loss) attributable to redeemable noncontrolling interest (13)                  
Other comprehensive income (loss), net of tax attributable to redeemable noncontrolling interests 2                  
Other 11                  
Ending Balance, redeemable noncontrolling interests at Dec. 31, 2020 0                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect of accounting change 6,789   6,789     1,367 4,149   1,273 0
Net income (loss) attributable to parent 1,995   1,995       1,995      
Net income (loss), including portion attributable to nonredeemable noncontrolling interest 1,995                 0
Other comprehensive income (loss) (1,154)   (1,154)           (1,154) 0
Other comprehensive income (loss), including portion attributable to noncontrolling interest (1,154)                  
Dividends (2,382)   (2,382)       (2,382)      
Shares issued:                    
Exercise of stock options, shares         1,208,964          
Exercise of stock options 59   59     59        
Restricted stock awards, shares         207,020          
Restricted stock awards 0   0     0        
Other benefit plans, shares         81,286          
Other benefit plans 10   10     10        
Dividend reinvestment plan, shares         69,095          
Dividend reinvestment plan 8   8     8        
Stock-based compensation expense 16   16     16        
Shares acquired and retired, shares         (2,777,684)          
Shares acquired and retired (319)   (319)     (44) (275)      
Shares exchanged — benefit plans, shares         (92,209)          
Shares exchanged — benefit plans $ (10)   (10)     (1) (9)      
Forfeitures of restricted stock, shares         (120,753)          
Ending Balance, shares at Dec. 31, 2021 84,920,965       84,920,965          
Ending Balance at Dec. 31, 2021 $ 5,012   5,012     1,415 3,478   119 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect of accounting change 5,012   5,012     1,415 3,478   119 0
Net income (loss) attributable to parent 898   898       898      
Net income (loss), including portion attributable to nonredeemable noncontrolling interest 898                 0
Other comprehensive income (loss) (662)   (662)           (662) 0
Other comprehensive income (loss), including portion attributable to noncontrolling interest (662)                  
Dividends $ (1,217)   (1,217)       (1,217)      
Shares issued:                    
Exercise of stock options, shares 182,054       182,054          
Exercise of stock options $ 7   7     7        
Restricted stock awards, shares         151,080          
Restricted stock awards 0   0     0        
Other benefit plans, shares         78,460          
Other benefit plans 10   10     10        
Dividend reinvestment plan, shares         33,794          
Dividend reinvestment plan 4   4     4        
Stock-based compensation expense 19   19     19        
Shares acquired and retired, shares         (89,368)          
Shares acquired and retired (11)   (11)     (1) (10)      
Shares exchanged — benefit plans, shares         (57,420)          
Shares exchanged — benefit plans $ (8)   (8)     (1) (7)      
Forfeitures of restricted stock, shares         (15,559)          
Ending Balance, shares at Dec. 31, 2022 85,204,006       85,204,006          
Ending Balance at Dec. 31, 2022 $ 4,052   4,052     1,453 3,142   (543) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect of accounting change $ 4,052   $ 4,052     $ 1,453 $ 3,142   $ (543) $ 0